Selection of B-cell chronic lymphocytic leukemia cell variants by therapy with anti-CD20 monoclonal antibody rituximab
- 1 December 2001
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 29 (12) , 1410-1416
- https://doi.org/10.1016/s0301-472x(01)00753-6
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Rituximab therapy of patients with B-cell chronic lymphocytic leukemiaBlood, 2001
- Rituximab Using A Thrice Weekly Dosing Schedule in B-Cell Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Demonstrates Clinical Activity and Acceptable ToxicityJournal of Clinical Oncology, 2001
- Rituximab Dose-Escalation Trial in Chronic Lymphocytic LeukemiaJournal of Clinical Oncology, 2001
- Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2000
- Chemosensitivity of B cell chronic lymphocytic leukemia and correlated expression of proteins regulating apoptosis, cell cycle and DNA repairLeukemia, 2000
- CLONAL SELECTION OF CD20‐NEGATIVE NON‐HODGKIN'S LYMPHOMA CELLS AFTER TREATMENT WITH ANTI‐CD20 ANTIBODY RITUXIMABBritish Journal of Haematology, 1999
- Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl.The Journal of Experimental Medicine, 1995
- Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemiaAmerican Journal of Hematology, 1992
- Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes.Proceedings of the National Academy of Sciences, 1989
- Structure of the human immunoglobulin μ locus: Characterization of embryonic and rearranged J and D genesCell, 1981